Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this clinical trial is to assessing safety and the occurrence of adverse effects during tele-rehabilitation (TRHB) in people with multiple sclerosis with an EDSS score of 6.5 or lower. The main questions it aims to answer are:
Researchers will compare the tele-rehabilitation with rehabilitation based solely on physical activity recommendations.
Participants will complete three weekly online rehabilitation sessions and must attend three follow-up visits.
Multiple Sclerosis (MS) often entails a series of difficulties that cause some people to have high rates of absenteeism or even prevent them from benefiting from in-person rehabilitation treatments. The onset of the disease at a very young age, when the person is actively working or studying, the difficulty of balancing work and family life, mobility issues and lack of transportation, and geographical dispersion are some of the reasons why people with MS are not always able to access a neurorehabilitation center. Scientific evidence shows that functional and social barriers are the most common reasons why people do not adhere to rehabilitation. Home-based tele-rehabilitation (TRHB) is an alternative to rehabilitation in centers, allowing for remote supervision and the elimination of barriers. In addition, TRHB provides affected individuals and their families/caregivers with greater support in terms of care, mobility, and access to these services, and according to the World Health Organization (WHO), this type of assistance improves access to the healthcare system. There is a gap in research to identify the main adverse events related to tele-rehabilitation, and it is important to understand how adverse events, such as falls during physical therapy, are associated with the delivery of tele-rehabilitation.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Intervention group: tele-rehabilitation | Experimental | This group will do online rehabilitation three times a week. Every two weeks, an assessment will be made to determine whether to increase the intensity of the exercise |
|
| Control group: physical activity recommendations | No Intervention | This group will only have access to basic recommendations for physical activity. |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Telerehab | Behavioral | Adverse events are observed during online rehabilitation with computer vision technology in patients with MS. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Adverse events | Adverse events such as falls, pain, fatigue, and others that may occur. | From enrollment to the end of treatment in week 8 |
| Measure | Description | Time Frame |
|---|---|---|
| Multiple Sclerosis Quality of Life 54 | Quality of life scale (Min.0; Max.100). The higher the score, the better. | (T1) baseline, (T2) after the 8 week, (T3) at 16 week. |
| 10 meters walking test |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Edwin R Meza Murillo, Dr | Multiple Sclerosis Center of Catalonia | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Multiple Sclerosis Center of Catalonia | Barcelona | 08035 | Spain |
| PubMed Identifier | Type | Citation | Retractions |
|---|---|---|---|
| 38381732 | Result | Yau T, McIntyre M, Chan J, Bhogal D, Andreoli A, Bayley M, Leochico CFD, Kua A, Guo M, Munce S. Adverse events associated with the delivery of telerehabilitation: A scoping review protocol. PLoS One. 2024 Feb 21;19(2):e0297908. doi: 10.1371/journal.pone.0297908. eCollection 2024. | |
| 39270413 | Result | Doherty F, Lynch P, Powell P, Monaghan K. Feasibility and effectiveness of telerehabilitation on mobility and balance function in multiple sclerosis: A systematic review and meta-analysis. J Neurol Sci. 2024 Nov 15;466:123214. doi: 10.1016/j.jns.2024.123214. Epub 2024 Sep 4. |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Jan 15, 2025 | Jul 4, 2025 | Prot_SAP_000.pdf |
| ICF | No | No | Yes | Informed Consent Form | Jan 15, 2025 | Jul 4, 2025 | ICF_001.pdf |
Not provided
| ID | Term |
|---|---|
| D009103 | Multiple Sclerosis |
| ID | Term |
|---|---|
| D020278 | Demyelinating Autoimmune Diseases, CNS |
| D020274 | Autoimmune Diseases of the Nervous System |
| D009422 | Nervous System Diseases |
| D003711 | Demyelinating Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D000069350 | Telerehabilitation |
| ID | Term |
|---|---|
| D012046 | Rehabilitation |
| D000359 | Aftercare |
| D003266 | Continuity of Patient Care |
| D005791 | Patient Care |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
The scale measures walking speed. There are no minimum or maximum measurements. The higher the reading, the better.
| (T1) baseline, (T2) after the 8 week, (T3) at 16 week. |
| 6 minute walking test | The scale measures capacity for effort. There are no minimum or maximum measurements. The higher the score, the better. | (T1) baseline, (T2) after the 8 week, (T3) at 16 week. |
| Berg Balance Scale | The scale measures the level of balance. Minimum measurement 0; maximum 56. The higher the reading, the better. | (T1) baseline, (T2) after the 8 week, (T3) at 16 week. |
| 33646409 | Result | Xiang XM, Bernard J. Telehealth in Multiple Sclerosis Clinical Care and Research. Curr Neurol Neurosci Rep. 2021 Feb 28;21(4):14. doi: 10.1007/s11910-021-01103-4. |
| Result | Harkey LC, Jung SM, Newton ER, Patterson A. Satisfacció del pacient amb la telesalud en entorns rurals: una revisió sistemàtica. Revista Internacional de Telerehabilitació. 2020;12(2):53-64. doi: 10.5195/ijt.2020.6303 |
| 30588276 | Result | Fjeldstad-Pardo C, Thiessen A, Pardo G. Telerehabilitation in Multiple Sclerosis: Results of a Randomized Feasibility and Efficacy Pilot Study. Int J Telerehabil. 2018 Dec 11;10(2):55-64. doi: 10.5195/ijt.2018.6256. eCollection 2018 Fall. |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
| D013812 |
| Therapeutics |
| D006296 | Health Services |
| D005159 | Health Care Facilities Workforce and Services |
| D017216 | Telemedicine |
| D003695 | Delivery of Health Care |
| D010346 | Patient Care Management |
| D006298 | Health Services Administration |